Hospital Saint Joan de Deu

Barcelona 8950

1 studies enrolling now · 4 studies all time

What they study most

Cystic Fibrosis, Extreme Prematurity - Less Than 28 Weeks, Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome

Studies at this site

• ATTUNE: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intrathecally-Administered ION440 in Participants With Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome (MDS) — Recruiting now
• A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy — Running, not enrolling
• A Phase 3 Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Heterozygous for F508del and a Minimal Function Mutation (F/MF) — Completed
• Study of Room Air Versus 60% Oxygen for Resuscitation of Premature Infants — Stopped early